N. Inanc Et Al. , "UNINTENTIONAL MONOTHERAPY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB AND DRUG SURVIVAL RATE OF TOFACITINIB," ANNALS OF THE RHEUMATIC DISEASES , vol.81, pp.1338, 2022
Inanc, N. Et Al. 2022. UNINTENTIONAL MONOTHERAPY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB AND DRUG SURVIVAL RATE OF TOFACITINIB. ANNALS OF THE RHEUMATIC DISEASES , vol.81 , 1338.
Inanc, N., Abacar, K., ÖZTÜRK, A. M., Tufan, A., Karadeniz, H., Sari, I., ... Can, G.(2022). UNINTENTIONAL MONOTHERAPY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB AND DRUG SURVIVAL RATE OF TOFACITINIB. ANNALS OF THE RHEUMATIC DISEASES , vol.81, 1338.
Inanc, N. Et Al. "UNINTENTIONAL MONOTHERAPY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB AND DRUG SURVIVAL RATE OF TOFACITINIB," ANNALS OF THE RHEUMATIC DISEASES , vol.81, 1338, 2022
Inanc, N. Et Al. "UNINTENTIONAL MONOTHERAPY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB AND DRUG SURVIVAL RATE OF TOFACITINIB." ANNALS OF THE RHEUMATIC DISEASES , vol.81, pp.1338, 2022
Inanc, N. Et Al. (2022) . "UNINTENTIONAL MONOTHERAPY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB AND DRUG SURVIVAL RATE OF TOFACITINIB." ANNALS OF THE RHEUMATIC DISEASES , vol.81, p.1338.
@article{article, author={N. Inanc Et Al. }, title={UNINTENTIONAL MONOTHERAPY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB AND DRUG SURVIVAL RATE OF TOFACITINIB}, journal={ANNALS OF THE RHEUMATIC DISEASES}, year=2022, pages={1338} }